Global Cell-based Flu Vaccine Revenue Market Share Forecast by Type 2023-2028 Table 111.
Individual EU nations are free to find out whether or not or to not allow entry to worldwide travellers vaccinated with different coronavirus vaccines.
Sinovac continues to seek regulatory approval for CoronaVac in other countries while contributing to making the COVID-19 vaccine accessible and affordable globally to ensure the prevention and control of the COVID-19 pandemic.
As the vaccines are still new, their effectiveness is still being extensively trialed and thus there is no certainty that one is better than the other.
Global Cell-based Flu Vaccine Revenue Market Share by Region 2017-2022 Figure 18.
.